118 related articles for article (PubMed ID: 34963420)
1. Serum lipid trajectories in the years before a lymphoma diagnosis.
Fortuny J; Plana E; Kaye JA
Leuk Lymphoma; 2022 Feb; 63(2):291-303. PubMed ID: 34963420
[TBL] [Abstract][Full Text] [Related]
2. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.
Alford SH; Divine G; Chao C; Habel LA; Janakiraman N; Wang Y; Feigelson HS; Scholes D; Roblin D; Epstein MM; Engel L; Havstad S; Wells K; Yood MU; Fortuny J; Johnson CC;
Cancer Causes Control; 2018 Jan; 29(1):143-156. PubMed ID: 29192350
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years.
Rafiq M; Abel G; Renzi C; Lyratzopoulos G
Br J Gen Pract; 2022 Aug; 72(721):e546-e555. PubMed ID: 35817582
[TBL] [Abstract][Full Text] [Related]
4. Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece.
Petridou ET; Dikalioti SK; Skalkidou A; Andrie E; Dessypris N; Trichopoulos D;
Cancer Causes Control; 2007 Nov; 18(9):1031-7. PubMed ID: 17653828
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease.
Sergentanis TN; Kanavidis P; Michelakos T; Petridou ET
Eur J Cancer Prev; 2013 Mar; 22(2):131-50. PubMed ID: 22759975
[TBL] [Abstract][Full Text] [Related]
6. Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: A case-control study.
Etter JL; Cannioto R; Soh KT; Alquassim E; Almohanna H; Dunbar Z; Joseph JM; Balderman S; Hernandez-Ilizaliturri F; Moysich KB
Leuk Res; 2018 Jun; 69():7-11. PubMed ID: 29609041
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
9. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
[TBL] [Abstract][Full Text] [Related]
10. Value of serum copper measurement in lymphomas and several other malignancies.
Mortazavi SH; Bani-Hashemi A; Mozafari M; Raffi A
Cancer; 1972 May; 29(5):1193-8. PubMed ID: 4553758
[No Abstract] [Full Text] [Related]
11. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.
Hochberg J; Waxman IM; Kelly KM; Morris E; Cairo MS
Br J Haematol; 2009 Jan; 144(1):24-40. PubMed ID: 19087093
[TBL] [Abstract][Full Text] [Related]
12. Lipid content of malignant lymphomas.
Wright DH
J Clin Pathol; 1968 Sep; 21(5):643-9. PubMed ID: 4880412
[TBL] [Abstract][Full Text] [Related]
13. [Clinical practice guideline for lympoma in China (2021 Edition)].
; ;
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):707-735. PubMed ID: 34289565
[TBL] [Abstract][Full Text] [Related]
14. [Histocytologic comparison in the diagnosis of hematosarcomas].
Gérard-Marchant R; Schlumberger JR; Schneider M; Cattan A; Schneiberg K
Sem Hop; 1967 Feb; 43(7):435-8. PubMed ID: 4292919
[No Abstract] [Full Text] [Related]
15. Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network.
Martinez G; Walschaerts M; Le Mitouard M; Borye R; Thomas C; Auger J; Berthaut I; Brugnon F; Daudin M; Moinard N; Ravel C; Saias J; Szerman E; Rives N; Hennebicq S; Bujan L
Fertil Steril; 2017 Feb; 107(2):341-350.e5. PubMed ID: 27810161
[TBL] [Abstract][Full Text] [Related]
16. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
[TBL] [Abstract][Full Text] [Related]
17. [Hyperprolactinemia in malignant lymphomas].
Grobe N; Rühle H; Eckelmann G
Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764
[TBL] [Abstract][Full Text] [Related]
18. Leukaemia and allied disorders. 3. Clinical findings in 200 personal cases.
Woodliff HJ
Med J Aust; 1972 Aug; 2(8):408-13. PubMed ID: 4628709
[No Abstract] [Full Text] [Related]
19. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases.
Yenice N; Güllük F; Arican N; Türkmen S
Turk J Gastroenterol; 2003 Sep; 14(3):173-6. PubMed ID: 14655060
[TBL] [Abstract][Full Text] [Related]
20. Fine needle aspiration cytopathology of malignant lymphoma.
Wakely PE
Clin Lab Med; 1998 Sep; 18(3):541-59, vi-vii. PubMed ID: 9742382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
